12:00 AM
 | 
Sep 12, 2016
 |  BC Extra  |  Financial News

Advantagene raises $14.2M

Immuno-oncology company Advantagene Inc. (Auburndale, Mass.) raised $14.2 million in a series A round from undisclosed investors. The National Securities Corp. subsidiary of National Holdings Corp. (NASDAQ:NHLD) was the placement agent.

The funding is Advantagene's first significant...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >